OTC Drug and Dietary Supplement Market Forecasts to 2027 - Covid-19 Impact & Global Analysis by Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded and Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others), and Geography

Publication Month: Aug 2020 | Report Code: TIPRE00012956 | No. of Pages: 200 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The OTC Drug and Dietary Supplement Market was valued at US$ 2, 93,255.40million in 2019and is projected to reach US$ 4, 92,102.49millionby 2027; it is expected to grow at a CAGR of 6.8%from 2020to 2027.

 

Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical  conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. However, buying a dietary supplement with medicinal ingredients requires a prescription from a physicianwhen a person is critically ill or requires treatment. These OTC drugs and nutritional supplements have two forms: branded or generic.

                                                   

The scope of the OTC drug and dietary supplements market includes product, type, form, distribution channel, and region. The market for OTC drug and dietary supplement is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the OTC drug and dietary supplements market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.


Lucrative Regions for OTC Drug and Dietary Supplement Market

Lucrative Regions for OTC Drug and Dietary Supplement Market

Get more information on this report :


Market Insights

Growing Awareness Regarding General Health Issues

People nowadays are well aware of general health issues such as cold, cough, allergies, fever, pain, acidity, diarrhea, and skin-related conditions. Major population is focused on having healthy lifestyle by avoiding the consumption of junk food that leads to a rise in lifestyle-related diseases such as diabetes, obesity, and cardiovascular diseases. Growing preference toward maintaining the healthy lifestyle also leads to the consumption of weight-loss products and dietary supplements, such as vitamins, minerals, and supplements. Increase in exposure to the internet has led to greater access to dietary supplements and over the counter (OTC) drugs to consumers, at affordable prices.

 

The common health issues can be seasonal or they might occur due to minor changes in routine habits; hence, people prefer taking OTC medicines to treat them instead of visiting a doctor. In many cases, this saves time and money, and provides immediate relief. Several governments have initiated various programs toward health awareness, due to which there has been a quick and smooth adoption of everyday technology for healthcare and wellness, contributing to the industry's overall growth. For instance, in India, the government is taking positive steps toward formalizing the use of OTC medicines. Prescription monitoring programs (PMPs) collect, monitor, and analyze electronically transmitted prescribing and dispensing data submitted by pharmacies and dispensing practitioners. This data is then used to prevent OTC drug abuse. Thus, promoting the sale of OTC drugs.

 

Advancements in the pharmaceutical industry, such as predictive modeling, mobile apps, robotics, and diagnostics, are opening new avenues for pharmacists, which can improve their ability to dispense medication, minimize errors, and monitor patient adherence. Rightly dispensed medicinal product will not result in any type of drug abuse, which further builds confidence of the repurchase of OTC products and dietary supplements. Thus, the awareness of general health concerns and advancements in the pharmaceutical industry are driving market growth.

                                                   

OTC Drug and Dietary Supplement Product-Based Insights                            

Based on product, the OTC drug and dietary supplement market is segmented into cough and cold products, vitamins and dietary supplements, analgesics, gastrointestinal products, sleep aids, oral care products, ophthalmic products, antacids, feminine care, and others.

 

In 2019, the analgesicssegment accounted for the highest share of the market. Growth of this segment is attributed to the growing awareness regarding general health issuesand growing preference for non-prescription drugs over prescription drugs across the world. However, vitamins and dietary supplementssegmentis likely to register the highest CAGR in the global OTC drug and dietary supplementsmarket during the forecast period.

                                                                                                

Global OTC Drug and Dietary Supplement Market, by OTC Drug and Dietary Supplement Type– 2019& 2027

Global OTC Drug and Dietary Supplement Market, by OTC Drug and Dietary Supplement Type– 2019& 2027

Get more information on this report :


Type-BasedInsights

Based on type, the OTC drug and dietary supplements market is segmented into branded and generic. The genericsegment held a larger share of the market in 2019; whereas, the samesegment is estimated to register a higher CAGR of 7.1% in the market during the forecast period.

 

Form -Based Insights

Based on form, the OTC drug and dietary supplements market is segmented into tablets, capsules, powders, ointments, liquid, and others. The tabletssegment held the largest share of the market in 2019 and is estimated to register the highest CAGR of 7.5% in the market during the forecast period.

                                          

Basedon distribution channel, the OTC drug and dietary supplements market is segmented into hospital and retail pharmacies, retail stores, online channels, and others. The hospital and retail pharmaciessegment held the largest share of the market in 2019;however, the online channelssegment is estimated to register the highest CAGR of 7.5% in the market during the forecast period.                     

                                                   

Product launches and expansion strategies are commonly adopted by companies to expand their footprint and product portfolio worldwideas well as tomeet the growing demand.

 

The market players operating in the OTC drug and dietary supplement market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

By Product

  • Cough and Cold Products
  • Vitamins and Dietary Supplements
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Oral Care Products
  • Ophthalmic Products
  • Antacids
  • Feminine Care
  • Others


By Type                                        

  • Branded
  • Generic


By Form

  • Tablets
  • Capsules
  • Powders
  • Ointments
  • Liquid
  • Others


By Distribution Channel

  • Hospital and Retail Pharmacies
  • Retail Stores
  • Online Channels
  • Others


By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

 

Company Profiles

  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        OTC drug and Dietary Supplement– By Product

1.3.2        OTC Drug and Dietary Supplement– By Type

1.3.3        OTC Drug and Dietary Supplement– By Form

1.3.4        OTC Drug and Dietary Supplement – By Distribution Channel

1.3.5        Global OTC Drug and Dietary Supplement– By Geography

2.             OTC Drug and Dietary Supplement – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global OTC Drug And Dietary Supplement– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             OTC Drug and Dietary Supplement – Key Market Dynamics

5.1       Market Drivers

5.1.1        Growing Awareness Regarding General Health Issues

5.1.2        Growing Preference for Non-Prescription Drugs over Prescription Drugs

5.2       Market Restraints

5.2.1        Stringent FDA Regulations Related to Safety and Efficacy of OTC Drugs

5.3       Market Opportunities

5.3.1        R&D Activities by Market Players to Offer Improved OTC Drugs

5.4       Future Trends

5.4.1        Selection of OTC Drugs for Minor Diseases

5.5       Impact Analysis

6.             OTC Drug and Dietary Supplement – Global Analysis

6.1       Global OTC Drug and Dietary Supplement Revenue Forecast And Analysis

6.2       Global OTC Drug and Dietary Supplement, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             OTC Drug and Dietary Supplement Analysis – By Product

7.1       Overview

7.2       OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)

7.3       Cough and Cold Products

7.3.1        Overview

7.3.2        Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.4       Vitamins and Dietary Supplements

7.4.1        Overview

7.4.2        Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.5       Analgesics

7.5.1        Overview

7.5.2        Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.6       Gastrointestinal Products

7.6.1        Overview

7.6.2        Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

7.7       Sleep Aids

7.7.1        Overview

7.7.2        Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.8       Oral Care Products

7.8.1        Overview

7.8.2        Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.9       Ophthalmic Products

7.9.1        Overview

7.9.2        Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.10    Antacids

7.10.1     Overview

7.10.2     Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.11    Feminine Care

7.11.1     Overview

7.11.2     Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

7.12    Others

7.12.1     Overview

7.12.2     Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

8.             OTC Drug and Dietary Supplement Analysis – By Type

8.1       Overview

8.2       OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)

8.3       Branded

8.3.1        Overview

8.3.2        Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

8.4       Generic

8.4.1        Overview

8.4.2        Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.             OTC Drug and Dietary Supplement Analysis – By Form

9.1       Overview

9.2       OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)

9.3       Tablets

9.3.1        Overview

9.3.2        Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.4       Capsules

9.4.1        Overview

9.4.2        Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.5       Powders

9.5.1        Overview

9.5.2        Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.6       Ointments

9.6.1        Overview

9.6.2        Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.7       Liquid

9.7.1        Overview

9.7.2        Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9.8       Others

9.8.1        Overview

9.8.2        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.          OTC Drug and Dietary Supplement Analysis – By Distribution Channel

10.1    Overview

10.2    OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)

10.3    Hospital and Retail Pharmacies

10.3.1     Overview

10.3.2     Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.4    Retail Stores

10.4.1     Overview

10.4.2     Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.5    Online Channels

10.5.1     Overview

10.5.2     Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10.6    Others

10.6.1     Overview

10.6.2     Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

11.          OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis

11.1    North America: OTC Drug and Dietary Supplement Market

11.1.1     Overview

11.1.2     North America: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.3     North America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

11.1.4     North America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027  (USD Million)

11.1.5     North America: OTC Drug and Dietary Supplement Market, By Form – Revenue and Forecast to 2027  (USD Million)

11.1.6     North America: OTC Drug and Dietary Supplement Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.7     North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.1.8     US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.8.1    US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.8.2    US: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.8.3    US: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.8.4    US: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.8.5    US: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.1.9     Canada: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.9.1    Canada: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.9.2    Canada: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.9.3    Canada: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.9.4    Canada: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.9.5    Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.1.10   Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.1.10.3 Mexico: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.1.10.4 Mexico: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.1.10.5 Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.2    Europe: OTC Drug and Dietary Supplement Market

11.2.1     Overview

11.2.2     Europe: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.3     Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

11.2.4     Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027  (USD Million)

11.2.5     Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027  (USD Million)

11.2.6     Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.2.7     Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.2.8     Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.8.1    Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.8.2    Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.2.8.3    Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.2.8.4    Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.2.8.5    Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.2.9     France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.9.1    France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.9.2    France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.2.9.3    France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.2.9.4    France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.2.9.5    France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.2.10   UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.10.1 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.10.2 UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.2.10.3 UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.2.10.4 UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.2.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.2.11   Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.11.1 Italy: OTC Drug and Dietary Supplement Market,– Revenue and Forecast to 2027 (USD Million)

11.2.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.2.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.2.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.2.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.2.12   Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.12.1 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.2.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.2.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.2.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.2.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.3    Asia-Pacific: OTC Drug and Dietary Supplement Market

11.3.1     Overview

11.3.2     Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)

11.3.3     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.4     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027  (USD Million)

11.3.5     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027  (USD Million)

11.3.6     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.3.7     Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.3.8     China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.3.8.1    China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

11.3.8.2    China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.8.3    China: OTC Drug and Dietary Supplement Market,, by Type – Revenue and Forecast to 2027 (USD Million)

11.3.8.4    China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.3.8.5    China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.3.9     Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.1    Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.2    Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.9.3    Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.3.9.4    Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.3.9.5    Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.3.10   India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.1 India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.2 India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.10.3 India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.3.10.4 India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.3.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.3.11   South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.1 South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.3.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.3.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.3.12   Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.1 Australia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.3.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.3.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.3.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.4    Middle East & Africa: OTC Drug and Dietary Supplement Market

11.4.1     Overview

11.4.2     Middle East & Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027  (US$ Million)

11.4.3     Middle East & Africa OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)

11.4.4     Middle East & Africa OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027  (USD Million)

11.4.5     Middle East & Africa OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

11.4.6     Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.4.7     Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.4.8     Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.1    Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.2    Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.4.8.3    Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.4.8.4    Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.4.8.5    Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

11.4.9     UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.1    UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.2    UAE: OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)

11.4.9.3    UAE: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.4.9.4    UAE: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.4.9.5    UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.4.10   South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.10.1 South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.4.10.2 South Africa: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.4.10.3 South Africa: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.4.10.4 South Africa: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.4.10.5 South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

11.5    South and Central America: OTC Drug and Dietary Supplement Market

11.5.1     Overview

11.5.2     South and Central America: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.5.3     South and Central America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.5.4     South and Central America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.5.5     South and Central America: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.5.6     South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

11.5.7     South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

11.5.8     Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.1    Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.2    Brazil: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.5.8.3    Brazil: OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027 (USD Million)

11.5.8.4    Brazil: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.5.8.5    Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.5.9     Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.1    Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.2    Argentina: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

11.5.9.3    Argentina: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.5.9.4    Argentina: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

11.5.9.5    Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

12.          Impact of COVID-19 Pandemic on Global OTC Drug And Dietary Supplement Market

12.1    North America: Impact Assessment of COVID-19 Pandemic

12.2    Europe: Impact Assessment of COVID-19 Pandemic

12.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

13.          OTC Drug and Dietary Supplement Market– Industry Landscape

13.1    Overview

13.2    Growth Strategies Done by the Companies in the Market, (%)

13.3    Organic Developments

13.3.1     Overview

13.4    Inorganic Developments

13.4.1     Overview

14.          COMPANY PROFILES

14.1    GlaxoSmithKline plc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    Sanofi

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    Johnson and Johnson Services, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    Abbott

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    AbbVie Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    Bausch Health Companies Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    Bayer AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    Procter & Gamble

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Novartis AG

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10 Reckitt Benckiser Group Plc

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.          Appendix

15.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 2.             North America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 3.             North America: OTC Drug and Dietary Supplement Market, By Form – Revenue and Forecast to 2027  (USD Million)

Table 4.             North America: OTC Drug and Dietary Supplement Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             US: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 9.             Canada: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Mexico: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Mexico: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 18.          Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 20.          Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 22.          Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 24.          Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 26.          France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 28.          France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.          UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 30.          UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 31.          UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 32.          UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 33.          Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 34.          Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35.          Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 36.          Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 37.          Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 38.          Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 40.          Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 41.          Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 42.          Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 44.          Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 45.          China: OTC Drug and Dietary Supplement Market,, by Product – Revenue and Forecast to 2027 (USD Million)

Table 46.          China: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 47.          China: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 48.          China: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 49.          Japan: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 50.          Japan: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 51.          Japan: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 52.          Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 53.          India: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 54.          India: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 55.          India: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 56.          India: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 57.          South Korea OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 58.          South Korea OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 59.          South Korea: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 60.          South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 61.          Australia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 62.          Australia OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 63.          Australia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 64.          Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 65.          Middle East & Africa OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 66.          Middle East & Africa OTC Drug and Dietary Supplement Market, by Type– Revenue and Forecast to 2027  (USD Million)

Table 67.          Middle East & Africa OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 68.          Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 69.          Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 70.          Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 71.          Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

Table 72.          Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

Table 73.          UAE: OTC Drug and Dietary Supplement Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 74.          UAE: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 75.          UAE: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

Table 76.          UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 77.          South Africa: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 78.          South Africa: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 79.          South Africa: OTC Drug and Dietary Supplement Market, by Form– Revenue and Forecast to 2027(USD Million)

Table 80.          South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel– Revenue and Forecast to 2027(USD Million)

Table 81.          South and Central America: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 82.          South and Central America: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 83.          South and Central America: OTC Drug and Dietary Supplement Market, by Form– Revenue and Forecast to 2027(USD Million)

Table 84.          South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 85.          Brazil: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 86.          Brazil: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 87.          Brazil: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

Table 88.          Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

Table 89.          Argentina: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 90.          Argentina: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 91.          Argentina: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027(USD Million)

Table 92.          Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)

Table 93.          Organic Developments Done By Companies

Table 94.          Inorganic Developments Done By Companies

Table 95.          Glossary of Terms, OTC Drug and Dietary Supplement

 

LIST OF FIGURES

Figure 1.           OTC Drug and Dietary Supplement Segmentation

Figure 2.           OTC Drug and Dietary Supplement– By Geography

Figure 3.           OTC Drug and Dietary Supplement Overview

Figure 4.           Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           OTC Drug and Dietary Supplement, by Geography (US$ Million)

Figure 7.           Global OTC Drug and Dietary Supplement – Leading Country Markets (US$ Million)

Figure 8.           Global OTC Drug and Dietary Supplement, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints

Figure 15.        Global OTC Drug and Dietary Supplement – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global OTC Drug and Dietary Supplement – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global OTC Drug and Dietary Supplement

Figure 18.        OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)

Figure 19.        Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

Figure 21.        Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)

Figure 30.        Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)

Figure 33.        Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 38.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 39.        OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)

Figure 40.        Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027  (US$ Million)

Figure 41.        Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 42.        Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 43.        Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

Figure 44.        North America: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)

Figure 45.        North America: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)

Figure 46.        North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 47.        US: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Canada: OTC Drug And Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Mexico: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Europe: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)

Figure 51.        Europe: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)

Figure 52.        Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 53.        Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 54.        France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 55.        UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 56.        Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Spain: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)

Figure 59.        Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)

Figure 60.        Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 61.        China: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)

Figure 62.        Japan: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        India: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        South Korea: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        Australia: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)

Figure 66.        Middle East & Africa: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)

Figure 67.        Middle East & Africa OTC Drug and Dietary Supplement Market –Revenue and Forecast to 2027 (USD Million)

Figure 68.        Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 69.        Saudi Arabia: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 70.        UAE: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 71.        South Africa: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 72.        South and Central America: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019)  (USD Million)

Figure 73.        South and Central America OTC Drug and Dietary Supplement Market– Revenue and Forecast to 2027  (USD Million)

Figure 74.        South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)

Figure 75.        Brazil: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 76.        Argentina: OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (USD Million)

Figure 77.        Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement market in North American Countries

Figure 78.        Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in European Countries

Figure 79.        Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Asia Pacific Countries

Figure 80.        Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in Rest of the World

Figure 81.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - OTC Drug and Dietary Supplement Market

  1. GlaxoSmithKline plc.
  2. Sanofi
  3. Johnson and Johnson Services, Inc.
  4. Abbott
  5. AbbVie Inc.
  6. Bausch Health Companies Inc.
  7. Bayer AG
  8. Procter & Gamble
  9. Novartis AG           
  10. Reckitt Benckiser Group Plc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the OTC drug and dietary supplement market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global OTC drug and dietary supplement market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00012956
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two forms, such as branded or generic.

The growth of the market is attributed to growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the stringent FDA regulations related to safety and efficacy of OTC drugs is expected to hinder the market growth.

The use of OTC drugs to treat various health conditions has allowed saving healthcare expenditure. Also, the consumption of dietary supplements has helped in improving health and enhance immunity. Thus, the products have provided affordable treatment options for both consumers and the healthcare systems across the globe.

Pricing